Viz.ai, Sanofi and Regeneron to link for COPD management
The partnership is poised to increase patient impact, especially for those who would benefit from enhanced care co-ordination.
Drug Development
Skye and Arecor to develop higher formulation of CB1 inhibitor
Japan’s MHLW approves GSK’s Blenrep combos for multiple myeloma
Pfizer signs global licensing deal with 3SBio for bispecific antibody
Five years, one approval: Europe’s slow march on Alzheimer’s treatments
FDA approves Incyte’s retifanlimab combo for SCAC treatment
